Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-23 Option Award |
2025-01-27 4:30 pm |
N/A 2035-01-22 |
Arcus Biosciences Inc. | RCUS | Lacey David L. Director |
5,000 | $0 | 62,652 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 6:20 pm |
N/A 2034-06-05 |
Arcus Biosciences Inc. | RCUS | Lacey David L. Director |
32,400 | $0 | 81,652 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-20 7:25 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 8:08 pm |
N/A 2033-06-14 |
Arcus Biosciences Inc. | RCUS | Lacey David L. Director |
26,300 | $0 | 68,752 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:07 pm |
N/A 2023-06-12 |
Atreca Inc. | BCEL | Lacey David L. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-04 7:57 pm |
N/A 2033-05-03 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:23 pm |
N/A 2032-06-13 |
Arcus Biosciences Inc. | RCUS | Lacey David L. Director |
20,900 | $0 | 59,252 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 6:45 pm |
N/A 2032-06-07 |
Atreca Inc. | BCEL | Lacey David L. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 5:40 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:33 pm |
N/A 2031-06-08 |
Atreca Inc. | BCEL | Lacey David L. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:38 pm |
N/A 2031-06-02 |
Arcus Biosciences Inc. | RCUS | Lacey David L. Director |
17,100 | $0 | 52,452 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-24 7:49 pm |
N/A 2031-05-05 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
17,500 | $0 | 17,500 (Direct) |
View |
Ownership |
2020-07-23 6:52 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
0 | $0 | 99,999 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 5:27 pm |
N/A 2030-06-17 |
Unity Biotechnology Inc. | UBX | Lacey David L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-15 5:07 pm |
N/A 2030-06-09 |
Atreca Inc. | BCEL | Lacey David L. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 4:20 pm |
N/A 2030-05-20 |
Arcus Biosciences Inc. | RCUS | Lacey David L. Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-05-26 4:18 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Lacey David L. Director |
0 | $0 | 40,352 (Direct) |
View |